{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:17:32Z","timestamp":1792282652493,"version":"4.4.0"},"reference-count":156,"publisher":"Bentham Science Publishers Ltd.","issue":"27","funder":[{"DOI":"10.13039\/501100011470","name":"Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["17ZR1439100"],"award-info":[{"award-number":["17ZR1439100"]}],"id":[{"id":"10.13039\/501100011470","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007301","name":"Harvard University Center for AIDS Research","doi-asserted-by":"publisher","award":["5P30AI060354-14"],"award-info":[{"award-number":["5P30AI060354-14"]}],"id":[{"id":"10.13039\/100007301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,12,17]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The rapid development of nanotechnology has a great influence on the fields of biology,\nphysiology, and medicine. Over recent years, nanoparticles have been widely presented as nanocarriers\nto help the delivery of gene, drugs, and other therapeutic agents with cellular targeting ability. Advances\nin the understanding of gene delivery and RNA interference (RNAi)-based therapy have brought increasing\nattention to understanding and tackling complex genetically related diseases, such as cancer,\ncardiovascular and pulmonary diseases, autoimmune diseases and infections. The combination of nanocarriers\nand DNA\/RNA delivery may potentially improve their safety and therapeutic efficacy. However,\nthere still exist many challenges before this approach can be practiced in the clinic. In this review,\nwe provide a comprehensive summary on the types of nanoparticle systems used as nanocarriers, highlight\nthe current use of nanocarriers in recombinant DNA and RNAi molecules delivery, and the current\nlandscape of gene-based nanomedicine-ranging from diagnosis to therapeutics. Finally, we briefly discuss\nthe biosafety concerns and limitations in the preclinical and clinical development of nanoparticle\ngene systems.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026619666191024170212","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T10:09:45Z","timestamp":1572257385000},"page":"2507-2523","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Nanoparticle Delivery Systems for DNA\/RNA and their Potential Applications in Nanomedicine"],"prefix":"10.2174","volume":"19","author":[{"given":"Hua","family":"Shen","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Changhai Hospital, Second Military Medical University, Changhai Road 168#, Shanghai 200433, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Bethune International Peace Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguan","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli Aybike","family":"Dogan","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, 35100 Bornova-Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsheng","family":"Liu","sequence":"additional","affiliation":[{"name":"California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Central Laboratory, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Draz","sequence":"additional","affiliation":[{"name":"Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, Fengyang Road 415#, Shanghai 200003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.8493530","volume":"260","author":"Mulligan R.C.","year":"1993","unstructured":"Mulligan R.C.; The basic science of gene therapy. Science 1993,260(5110),926-932","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.gt.3301791","volume":"9","author":"Griesenbach U.","year":"2002","unstructured":"Griesenbach U.; Ferrari S.; Geddes D.M.; Alton E.W.; Gene therapy progress and prospects: cystic fibrosis. Gene Ther 2002,9(20),1344-1350","journal-title":"Gene Ther"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.gt.3302116","volume":"10","author":"Burton E.A.","year":"2003","unstructured":"Burton E.A.; Glorioso J.C.; Fink D.J.; Gene therapy progress and prospects: Parkinson\u2019s disease. Gene Ther 2003,10(20),1721-1727","journal-title":"Gene Ther"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.2174\/1573406413666170209122131","author":"Karponi G.","year":"2017","unstructured":"Karponi G.; Zogas N.; Domvri K.; Zarogoulidis P.; Trakada G.; Roumeliotis S.; Hohenforst-Schmidt W.; Darwiche K.; Freitag L.; Zarogoulidis K.; Prospects of gene therapy for pulmonary diseases: progress and limitations. Med Chem 2017","journal-title":"Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/mt.2013.216","volume":"22","author":"Martinez T.","year":"2014","unstructured":"Martinez T.; Gonzalez M.V.; Roehl I.; Wright N.; Paneda C.; Jimenez A.I.; In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma. Mol Ther 2014,22(1),81-91","journal-title":"Mol Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1073\/pnas.1406228111","volume":"111","author":"Yasuda M.","year":"2014","unstructured":"Yasuda M.; Gan L.; Chen B.; Kadirvel S.; Yu C.; Phillips J.D.; New M.I.; Liebow A.; Fitzgerald K.; Querbes W.; Desnick R.J.; RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice. Proc Natl Acad Sci USA 2014,111(21),7777-7782","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000360993","volume":"87","author":"Nemunaitis J.","year":"2014","unstructured":"Nemunaitis J.; Barve M.; Orr D.; Kuhn J.; Magee M.; Lamont J.; Bedell C.; Wallraven G.; Pappen B.O.; Roth A.; Horvath S.; Nemunaitis D.; Kumar P.; Maples P.B.; Senzer N.; Summary of bi-shRNA\/GM-CSF augmented autologous tumor cell immunotherapy (FANG\u2122) in advanced cancer of the liver. Oncology 2014,87(1),21-29","journal-title":"Oncology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-017-0683-y","volume":"16","author":"Xin Y","year":"2017","unstructured":"Xin Y; Huang M; Guo WW; Huang Q; Zhang LZ; Jiang G;  Nano-based delivery of RNAi in cancer therapy 2017,16(1),134","journal-title":"Nano-based delivery of RNAi in cancer therapy"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/B978-0-12-800148-6.00005-5","volume":"88","author":"Wang Y.","year":"2014","unstructured":"Wang Y.; Huang L.; Composite nanoparticles for gene delivery. Adv Genet 2014,88,111-137","journal-title":"Adv Genet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-017-0101-9","volume":"6","author":"Aguiar S.","year":"2017","unstructured":"Aguiar S.; van der Gaag B.; Cortese F.A.B.; RNAi mechanisms in Huntington\u2019s disease therapy: siRNA versus shRNA. Transl Neurodegener 2017,6,30","journal-title":"Transl Neurodegener"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.gt.3301983","volume":"10","author":"Herweijer H.","year":"2003","unstructured":"Herweijer H.; Wolff J.A.; Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 2003,10(6),453-458","journal-title":"Gene Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/sj.gt.3302337","volume":"11","author":"Wells D.J.","year":"2004","unstructured":"Wells D.J.; Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther 2004,11(18),1363-1369","journal-title":"Gene Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.gt.3302925","volume":"14","author":"Newman C.M.","year":"2007","unstructured":"Newman C.M.; Bettinger T.; Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 2007,14(6),465-475","journal-title":"Gene Ther"},{"key":"ref=14","first-page":"46","volume":"14","author":"Wang W.","year":"2013","unstructured":"Wang W.; Li W.; Ma N.; Steinhoff G.; Non-viral gene delivery methods. Curr Pharm Biotechnol 2013,14(1),46-60","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"Thomas C.E.","year":"2003","unstructured":"Thomas C.E.; Ehrhardt A.; Kay M.A.; Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003,4(5),346-358","journal-title":"Nat Rev Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrg2141","volume":"8","author":"Waehler R.","year":"2007","unstructured":"Waehler R.; Russell S.J.; Curiel D.T.; Engineering targeted viral vectors for gene therapy. Nat Rev Genet 2007,8(8),573-587","journal-title":"Nat Rev Genet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/bmj.329.7470.839","volume":"329","author":"Relph K.","year":"2004","unstructured":"Relph K.; Harrington K.; Pandha H.; Recent developments and current status of gene therapy using viral vectors in the United Kingdom. BMJ 2004,329(7470),839-842","journal-title":"BMJ"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/423573a","volume":"423","author":"Check E.","year":"2003","unstructured":"Check E.; Harmful potential of viral vectors fuels doubts over gene therapy. Nature 2003,423(6940),573-574","journal-title":"Nature"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1126\/science.294.5547.1640","volume":"294","author":"Marshall E.","year":"2001","unstructured":"Marshall E.; Gene therapy. Viral vectors still pack surprises. Science 2001,294(5547),1640","journal-title":"Science"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1358\/dnp.1998.11.5.863673","volume":"11","author":"Strayer D.S.","year":"1998","unstructured":"Strayer D.S.; Viral vectors for gene therapy: past, present and future. Drug News Perspect 1998,11(5),277-286","journal-title":"Drug News Perspect"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017434","volume":"5","author":"Burnight E.R.","year":"2014","unstructured":"Burnight E.R.; Wiley L.A.; Mullins R.F.; Stone E.M.; Tucker B.A.; Gene therapy using stem cells. Cold Spring Harb Perspect Med 2014,5(4)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.trsl.2013.01.001","volume":"161","author":"Simara P.","year":"2013","unstructured":"Simara P.; Motl J.A.; Kaufman D.S.; Pluripotent stem cells and gene therapy. Transl Res 2013,161(4),284-292","journal-title":"Transl Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","volume":"13","author":"Li S.D.","year":"2006","unstructured":"Li S.D.; Huang L.; Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 2006,13(18),1313-1319","journal-title":"Gene Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","volume":"9","author":"Niidome T.","year":"2002","unstructured":"Niidome T.; Huang L.; Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002,9(24),1647-1652","journal-title":"Gene Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","volume":"11","author":"Pelaz B.","year":"2017","unstructured":"Pelaz B.; Alexiou C.; Alvarez-Puebla R.A.; Alves F.; Andrews A.M.; Ashraf S.; Balogh L.P.; Ballerini L.; Bestetti A.; Brendel C.; Diverse applications of nanomedicine. ACS Nano 2017,11(3),2313-2381","journal-title":"ACS Nano"},{"key":"ref=26","author":"Soni S.","year":"2014","unstructured":"Soni S.;  Handbook of research on diverse applications of nanotechnology in biomedicine, chemistry, and engineering 2014","journal-title":"Handbook of research on diverse applications of nanotechnology in biomedicine, chemistry, and engineering"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.7150\/thno.9404","volume":"4","author":"Draz M.S.","year":"2014","unstructured":"Draz M.S.; Fang B.A.; Zhang P.; Hu Z.; Gu S.; Weng K.C.; Gray J.W.; Chen F.F.; Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections. Theranostics 2014,4(9),872-892","journal-title":"Theranostics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.7150\/thno.23856","volume":"8","author":"Draz M.S.","year":"2018","unstructured":"Draz M.S.; Shafiee H.; Applications of gold nanoparticles in virus detection. Theranostics 2018,8(7),1985-2017","journal-title":"Theranostics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1039\/C6BM00441E","volume":"4","author":"Keles E.","year":"2016","unstructured":"Keles E.; Song Y.; Du D.; Dong W.J.; Lin Y.; Recent progress in nanomaterials for gene delivery applications. Biomater Sci 2016,4(9),1291-1309","journal-title":"Biomater Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1021\/nn103130q","volume":"5","author":"Kim M.H.","year":"2011","unstructured":"Kim M.H.; Na H.K.; Kim Y.K.; Ryoo S.R.; Cho H.S.; Lee K.E.; Jeon H.; Ryoo R.; Min D.H.; Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano 2011,5(5),3568-3576","journal-title":"ACS Nano"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","volume":"55","author":"Panyam J.","year":"2003","unstructured":"Panyam J.; Labhasetwar V.; Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003,55(3),329-347","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=32","first-page":"169","volume":"3","author":"McBain S.C.","year":"2008","unstructured":"McBain S.C.; Yiu H.H.; Dobson J.; Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008,3(2),169-180","journal-title":"Int J Nanomedicine"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1126\/science.1125559","volume":"312","author":"Rosi N.L.","year":"2006","unstructured":"Rosi N.L.; Giljohann D.A.; Thaxton C.S.; Lytton-Jean A.K.; Han M.S.; Mirkin C.A.; Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006,312(5776),1027-1030","journal-title":"Science"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","volume":"172","author":"Ragelle H.","year":"2013","unstructured":"Ragelle H.; Vandermeulen G.; Preat V.; Chitosan-based siRNA delivery systems. J Control Release 2013,172(1),207-218","journal-title":"J Control Release"},{"key":"ref=35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148848","volume":"11","author":"Zhao Y.Z.","year":"2016","unstructured":"Zhao Y.Z.; Jin R.R.; Yang W.; Xiang Q.; Yu W.Z.; Lin Q.; Tian F.R.; Mao K.L.; Lv C.Z.; W\u00e1ng Y.X.; Lu C.T.; Using gelatin nanoparticle mediated intranasal delivery of neuropeptide substance P to enhance neuro-recovery in hemiparkinsonian rats. PLoS One 2016,11(2)","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"24368","DOI":"10.1021\/acsami.6b05907","volume":"8","author":"Wang S.","year":"2016","unstructured":"Wang S.; Zhao X.; Wang S.; Qian J.; He S.; Biologically inspired polydopamine capped gold nanorods for drug delivery and light-mediated cancer therapy. ACS Appl Mater Interfaces 2016,8(37),24368-24384","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1384658","volume":"2016","author":"Zhu K.","year":"2016","unstructured":"Zhu K.; Li J.; Wang Y.; Lai H.; Wang C.; Nanoparticles-assisted stem cell therapy for ischemic heart disease. Stem Cells Int 2016,2016","journal-title":"Stem Cells Int"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1016\/j.biomaterials.2013.04.032","volume":"34","author":"Duan J.","year":"2013","unstructured":"Duan J.; Yu Y.; Li Y.; Yu Y.; Sun Z.; Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 2013,34(23),5853-5862","journal-title":"Biomaterials"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tips.2010.01.003","volume":"31","author":"Godin B.","year":"2010","unstructured":"Godin B.; Sakamoto J.H.; Serda R.E.; Grattoni A.; Bouamrani A.; Ferrari M.; Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci 2010,31(5),199-205","journal-title":"Trends Pharmacol Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cardiores.2006.11.031","volume":"73","author":"Niu J.","year":"2007","unstructured":"Niu J.; Azfer A.; Rogers L.M.; Wang X.; Kolattukudy P.E.; Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007,73(3),549-559","journal-title":"Cardiovasc Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1016\/j.biomaterials.2010.07.077","volume":"31","author":"Wong Y.","year":"2010","unstructured":"Wong Y.; Markham K.; Xu Z.P.; Chen M.; Max Lu G.Q.; Bartlett P.F.; Cooper H.M.; Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 2010,31(33),8770-8779","journal-title":"Biomaterials"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nano.2008.01.002","volume":"4","author":"Roy I.","year":"2008","unstructured":"Roy I.; Stachowiak M.K.; Bergey E.J.; Nonviral gene transfection nanoparticles: function and applications in the brain. Nanomedicine (Lond) 2008,4(2),89-97","journal-title":"Nanomedicine (Lond)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"11539","DOI":"10.1073\/pnas.0504926102","volume":"102","author":"Bharali D.J.","year":"2005","unstructured":"Bharali D.J.; Klejbor I.; Stachowiak E.K.; Dutta P.; Roy I.; Kaur N.; Bergey E.J.; Prasad P.N.; Stachowiak M.K.; Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 2005,102(32),11539-11544","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","volume":"80","author":"Liu Y.","year":"2016","unstructured":"Liu Y.; An S.; Li J.; Kuang Y.; He X.; Guo Y.; Ma H.; Zhang Y.; Ji B.; Jiang C.; Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice. Biomaterials 2016,80,33-45","journal-title":"Biomaterials"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s11095-013-1005-8","volume":"30","author":"Huang R.","year":"2013","unstructured":"Huang R.; Ma H.; Guo Y.; Liu S.; Kuang Y.; Shao K.; Li J.; Liu Y.; Han L.; Huang S.; An S.; Ye L.; Lou J.; Jiang C.; Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson\u2019s disease. Pharm Res 2013,30(10),2549-2559","journal-title":"Pharm Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1021\/mp500656v","volume":"12","author":"Lin G.","year":"2015","unstructured":"Lin G.; Zhang H.; Huang L.; Smart polymeric nanoparticles for cancer gene delivery. Mol Pharm 2015,12(2),314-321","journal-title":"Mol Pharm"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.nano.2018.04.019","volume":"14","author":"Semkina A.S.","year":"2018","unstructured":"Semkina A.S.; Abakumov M.A.; Skorikov A.S.; Abakumova T.O.; Melnikov P.A.; Grinenko N.F.; Cherepanov S.A.; Vishnevskiy D.A.; Naumenko V.A.; Ionova K.P.; Majouga A.G.; Chekhonin V.P.; Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer. Nanomedicine (Lond) 2018,14(5),1733-1742","journal-title":"Nanomedicine (Lond)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.7150\/thno.27828","volume":"8","author":"Ray S.","year":"2018","unstructured":"Ray S.; Li Z.; Hsu C.H.; Hwang L.P.; Lin Y.C.; Chou P.T.; Lin Y.Y.; Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics. Theranostics 2018,8(22),6322-6349","journal-title":"Theranostics"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7150\/thno.17411","volume":"7","author":"Yang Y.","year":"2017","unstructured":"Yang Y.; Jing L.; Li X.; Lin L.; Yue X.; Dai Z.; Hyaluronic acid conjugated magnetic prussian blue@quantum dot nanoparticles for cancer theranostics. Theranostics 2017,7(2),466-481","journal-title":"Theranostics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7150\/thno.11544","volume":"5","author":"Gobbo O.L.","year":"2015","unstructured":"Gobbo O.L.; Sjaastad K.; Radomski M.W.; Volkov Y.; Prina-Mello A.; Magnetic nanoparticles in cancer theranostics. Theranostics 2015,5(11),1249-1263","journal-title":"Theranostics"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/mt.2010.136","volume":"18","author":"Chen Y.","year":"2010","unstructured":"Chen Y.; Zhu X.; Zhang X.; Liu B.; Huang L.; Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 2010,18(9),1650-1656","journal-title":"Mol Ther"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejpb.2007.07.011","volume":"68","author":"Choi S.H.","year":"2008","unstructured":"Choi S.H.; Jin S.E.; Lee M.K.; Lim S.J.; Park J.S.; Kim B.G.; Ahn W.S.; Kim C.K.; Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur J Pharm Biopharm 2008,68(3),545-554","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.biomaterials.2006.11.018","volume":"28","author":"Tan W.B.","year":"2007","unstructured":"Tan W.B.; Jiang S.; Zhang Y.; Quantum-dot based nanoparticles for targeted silencing of HER2\/neu gene via RNA interference. Biomaterials 2007,28(8),1565-1571","journal-title":"Biomaterials"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1470-2045(06)70793-8","volume":"7","author":"Yezhelyev M.V.","year":"2006","unstructured":"Yezhelyev M.V.; Gao X.; Xing Y.; Al-Hajj A.; Nie S.; O\u2019Regan R.M.; Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 2006,7(8),657-667","journal-title":"Lancet Oncol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"11878","DOI":"10.1158\/0008-5472.CAN-06-2354","volume":"66","author":"Lu W.","year":"2006","unstructured":"Lu W.; Sun Q.; Wan J.; She Z.; Jiang X.G.; Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 2006,66(24),11878-11887","journal-title":"Cancer Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1586\/1744666X.2015.995097","volume":"11","author":"Lemos H.","year":"2015","unstructured":"Lemos H.; Huang L.; McGaha T.; Mellor A.L.; STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy? Expert Rev Clin Immunol 2015,11(1),155-165","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1021\/nn5066793","volume":"9","author":"Liu Q.","year":"2015","unstructured":"Liu Q.; Chen X.; Jia J.; Zhang W.; Yang T.; Wang L.; Ma G.; pH-Responsive poly(D,L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response. ACS Nano 2015,9(5),4925-4938","journal-title":"ACS Nano"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/mt.2013.245","volume":"22","author":"Lee S.J.","year":"2014","unstructured":"Lee S.J.; Lee A.; Hwang S.R.; Park J.S.; Jang J.; Huh M.S.; Jo D.G.; Yoon S.Y.; Byun Y.; Kim, SH TNF-alpha gene silencing using polymerized siRNA\/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther 2014,22(2),397-408","journal-title":"Mol Ther"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.addr.2013.09.005","volume":"65","author":"Dumortier H.","year":"2013","unstructured":"Dumortier H.; When carbon nanotubes encounter the immune system: desirable and undesirable effects. Adv Drug Deliv Rev 2013,65(15),2120-2126","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/mt.2011.190","volume":"19","author":"Basha G.","year":"2011","unstructured":"Basha G.; Novobrantseva T.I.; Rosin N.; Tam Y.Y.; Hafez I.M.; Wong M.K.; Sugo T.; Ruda V.M.; Qin J.; Klebanov B.; Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther 2011,19(12),2186-2200","journal-title":"Mol Ther"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","volume":"172","author":"Ragelle H.","year":"2013","unstructured":"Ragelle H.; Vandermeulen G.; Preat V.; Chitosan-based siRNA delivery systems. J Control Release 2013,172(1),207-218","journal-title":"J Control Release"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2011.9","volume":"1","author":"Haussecker D.","year":"2012","unstructured":"Haussecker D.; The business of RNAi therapeutics in 2012. Mol Ther Nucleic Acids 2012,1","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.2147\/IJN.S137980","volume":"12","author":"Shen C.","year":"2017","unstructured":"Shen C.; Li J.; Zhang Y.; Li Y.; Shen G.; Zhu J.; Tao J.; Polyethylenimine-based micro\/nanoparticles as vaccine adjuvants. Int J Nanomedicine 2017,12,5443-5460","journal-title":"Int J Nanomedicine"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.talanta.2017.05.035","volume":"172","author":"Wu J.","year":"2017","unstructured":"Wu J.; Chen Y.; Wang Y.; Yin H.; Zhao Z.; Liu N.; Xie M.; Chen Y.; Poly-L-lysine brushes on magnetic nanoparticles for ultrasensitive detection of Escherichia coli O157: H7. Talanta 2017,172,53-60","journal-title":"Talanta"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2217\/nnm-2017-0328","volume":"13","author":"Devulapally R.","year":"2018","unstructured":"Devulapally R.; Lee T.; Barghava-Shah A.; Sekar T.V.; Foygel K.; Bachawal S.V.; Willmann J.K.; Paulmurugan R.; Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA\/PIE nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (Lond) 2018,13(9),1051-1066","journal-title":"Nanomedicine (Lond)"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11010-018-3352-6","volume":"449","author":"Chanphai P.","year":"2018","unstructured":"Chanphai P.; Tajmir-Riahi H.A.; Encapsulation of micronutrients resveratrol, genistein, and curcumin by folic acid-PAMAM nanoparticles. Mol Cell Biochem 2018,449(1-2),157-166","journal-title":"Mol Cell Biochem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.carbpol.2018.03.102","volume":"194","author":"Einafshar E.","year":"2018","unstructured":"Einafshar E.; Asl A.H.; Nia A.H.; Mohammadi M.; Malekzadeh A.; Ramezani M.; New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite. Carbohydr Polym 2018,194,103-110","journal-title":"Carbohydr Polym"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2217\/nnm.14.159","volume":"10","author":"Morales J.O.","year":"2015","unstructured":"Morales J.O.; Vald\u00e9s K.; Morales J.; Oyarzun-Ampuero F.; Lipid nanoparticles for the topical delivery of retinoids and derivatives. Nanomedicine (Lond) 2015,10(2),253-269","journal-title":"Nanomedicine (Lond)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.fsi.2018.05.055","volume":"80","author":"S\u00e1ez M.I.","year":"2018","unstructured":"S\u00e1ez M.I.; Vizca\u00edno A.J.; Alarc\u00f3n F.J.; Mart\u00ednez T.F.; Feed pellets containing chitosan nanoparticles as plasmid DNA oral delivery system for fish: In vivo assessment in gilthead sea bream (Sparus aurata) juveniles. Fish Shellfish Immunol 2018,80,458-466","journal-title":"Fish Shellfish Immunol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1006\/bbrc.2001.6133","volume":"289","author":"Honma K.","year":"2001","unstructured":"Honma K.; Ochiya T.; Nagahara S.; Sano A.; Yamamoto H.; Hirai K.; Aso Y.; Terada M.; Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions. Biochem Biophys Res Commun 2001,289(5),1075-1081","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.nano.2017.03.007","volume":"13","author":"Shafaei Z.","year":"2017","unstructured":"Shafaei Z.; Ghalandari B.; Vaseghi A.; Divsalar A.; Haertl\u00e9 T.; Saboury A.A.; Sawyer L.; \u03b2-Lactoglobulin: An efficient nanocarrier for advanced delivery systems. Nanomedicine (Lond) 2017,13(5),1685-1692","journal-title":"Nanomedicine (Lond)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.nano.2016.04.003","volume":"12","author":"C\u00e9spedes M.V.","year":"2016","unstructured":"C\u00e9spedes M.V.; Unzueta U.; \u00c1lamo P.; Gallardo A.; Sala R.; Casanova I.; Pav\u00f3n M.A.; Mangues M.A.; Tr\u00edas M.; L\u00f3pez-Pousa A.; Villaverde A.; V\u00e1zquez E.; Mangues R.; Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models. Nanomedicine (Lond) 2016,12(7),1987-1996","journal-title":"Nanomedicine (Lond)"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-60761-588-0_18","volume":"623","author":"H\u00f6bel S.","year":"2010","unstructured":"H\u00f6bel S.; Aigner A.; Polyethylenimine (PEI)\/siRNA-mediated gene knockdown in vitro and in vivo. Methods Mol Biol 2010,623,283-297","journal-title":"Methods Mol Biol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1472-6750-13-75","volume":"13","author":"Bire S.","year":"2013","unstructured":"Bire S.; Gosset D.; J\u00e9got G.; Midoux P.; Pichon C.; Rouleux-Bonnin F.; Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition. BMC Biotechnol 2013,13,75","journal-title":"BMC Biotechnol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12951-018-0365-y","volume":"16","author":"Tong W.Y.","year":"2018","unstructured":"Tong W.Y.; Alnakhli M.; Bhardwaj R.; Apostolou S.; Sinha S.; Fraser C.; Kuchel T.; Kuss B.; Voelcker N.H.; Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. J Nanobiotechnology 2018,16(1),38","journal-title":"J Nanobiotechnology"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1073\/pnas.96.9.5177","volume":"96","author":"Godbey W.T.","year":"1999","unstructured":"Godbey W.T.; Wu K.K.; Mikos A.G.; Tracking the intracellular path of poly(ethylenimine)\/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999,96(9),5177-5181","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.2174\/0929867311320290012","volume":"20","author":"Nayak T.R.","year":"2013","unstructured":"Nayak T.R.; Krasteva L.K.; Cai W.; Multimodality imaging of RNA interference. Curr Med Chem 2013,20(29),3664-3675","journal-title":"Curr Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.actbio.2018.03.030","volume":"72","author":"Wu D.","year":"2018","unstructured":"Wu D.; Zhang Y.; Xu X.; Guo T.; Xie D.; Zhu R.; Chen S.; Ramakrishna S.; He L.; RGD\/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration. Acta Biomater 2018,72,266-277","journal-title":"Acta Biomater"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.biomaterials.2012.12.038","volume":"34","author":"Liu C.","year":"2013","unstructured":"Liu C.; Liu F.; Feng L.; Li M.; Zhang J.; Zhang N.; The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials 2013,34(10),2547-2564","journal-title":"Biomaterials"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nmat4497","volume":"15","author":"Conde J.","year":"2016","unstructured":"Conde J.; Oliva N.; Atilano M.; Song H.S.; Artzi N.; Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment. Nat Mater 2016,15(3),353-363","journal-title":"Nat Mater"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2007.07.016","volume":"123","author":"Zhang S.","year":"2007","unstructured":"Zhang S.; Zhao B.; Jiang H.; Wang B.; Ma B.; Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007,123(1),1-10","journal-title":"J Control Release"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"Whitehead K.A.","year":"2009","unstructured":"Whitehead K.A.; Langer R.; Anderson D.G.; Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009,8(2),129-138","journal-title":"Nat Rev Drug Discov"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","volume":"31","author":"Kedmi R.","year":"2010","unstructured":"Kedmi R.; Ben-Arie N.; Peer D.; The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials 2010,31(26),6867-6875","journal-title":"Biomaterials"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/mt.2010.282","volume":"19","author":"Tao W.","year":"2011","unstructured":"Tao W.; Mao X.; Davide J.P.; Ng B.; Cai M.; Burke P.A.; Sachs A.B.; Sepp-Lorenzino, L Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses. Mol Ther 2011,19(3),567-575","journal-title":"Mol Ther"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/mabi.200700188","volume":"8","author":"Peng C.C.","year":"2008","unstructured":"Peng C.C.; Yang M.H.; Chiu W.T.; Chiu C.H.; Yang C.S.; Chen Y.W.; Chen K.C.; Peng R.Y.; Composite nano-titanium oxide-chitosan artificial skin exhibits strong wound-healing effect-an approach with anti-inflammatory and bactericidal kinetics. Macromol Biosci 2008,8(4),316-327","journal-title":"Macromol Biosci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1023\/A:1018901302450","volume":"11","author":"Illum L.","year":"1994","unstructured":"Illum L.; Farraj N.F.; Davis S.S.; Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 1994,11(8),1186-1189","journal-title":"Pharm Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.carbpol.2018.04.087","volume":"195","author":"Guo X.","year":"2018","unstructured":"Guo X.; Zhuang Q.; Ji T.; Zhang Y.; Li C.; Wang Y.; Li H.; Jia H.; Liu Y.; Du L.; Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer. Carbohydr Polym 2018,195,311-320","journal-title":"Carbohydr Polym"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/1061186X.2014.1000336","volume":"23","author":"Song H.","year":"2015","unstructured":"Song H.; Oh B.; Choi M.; Oh J.; Lee M.; Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy. J Drug Target 2015,23(4),360-370","journal-title":"J Drug Target"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.biomaterials.2018.11.027","volume":"192","author":"Ji Y.","year":"2019","unstructured":"Ji Y.; Liu X.; Huang M.; Jiang J.; Liao Y-P.; Liu Q.; Chang C.H.; Liao H.; Lu J.; Wang X.; Spencer M.J.; Meng H.; Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo. Biomaterials 2019,192,416-428","journal-title":"Biomaterials"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1021\/nn900813b","volume":"3","author":"Neely A.","year":"2009","unstructured":"Neely A.; Perry C.; Varisli B.; Singh A.K.; Arbneshi T.; Senapati D.; Kalluri J.R.; Ray P.C.; Ultrasensitive and highly selective detection of Alzheimer\u2019s disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle. ACS Nano 2009,3(9),2834-2840","journal-title":"ACS Nano"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2131\/jts.40.263","volume":"40","author":"Ghaderi S.","year":"2015","unstructured":"Ghaderi S.; Tabatabaei S.R.; Varzi H.N.; Rashno M.; Induced adverse effects of prenatal exposure to silver nanoparticles on neurobehavioral development of offspring of mice. J Toxicol Sci 2015,40(2),263-275","journal-title":"J Toxicol Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1007\/s00216-014-7882-9","volume":"406","author":"Seia M.A.","year":"2014","unstructured":"Seia M.A.; Pereira S.V.; Fern\u00e1ndez-Baldo M.A.; De Vito I.E.; Raba J.; Messina G.A.; Zinc oxide nanoparticles based microfluidic immunosensor applied in congenital hypothyroidism screening. Anal Bioanal Chem 2014,406(19),4677-4684","journal-title":"Anal Bioanal Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.colsurfb.2018.05.040","volume":"169","author":"Abhinayaa R.","year":"2018","unstructured":"Abhinayaa R.; Jeevitha G.; Mangalaraj D.; Ponpandian N.; Vidhya K.; Angayarkanni J.; Cytotoxic consequences of Halloysite nanotube\/iron oxide nanocomposite and iron oxide nanoparticles upon interaction with bacterial, non-cancerous and cancerous cells. Colloids Surf B Biointerfaces 2018,169,395-403","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/C1NR11188D","volume":"4","author":"Yeh Y.C.","year":"2012","unstructured":"Yeh Y.C.; Creran B.; Rotello V.M.; Gold nanoparticles: preparation, properties, and applications in bionanotechnology. Nanoscale 2012,4(6),1871-1880","journal-title":"Nanoscale"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-015-0133-1","volume":"13","author":"Sela H.","year":"2015","unstructured":"Sela H.; Cohen H.; Elia P.; Zach R.; Karpas Z.; Zeiri Y.; Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). J Nanobiotechnology 2015,13,71","journal-title":"J Nanobiotechnology"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1021\/nn5008572","volume":"8","author":"Huo S.","year":"2014","unstructured":"Huo S.; Jin S.; Ma X.; Xue X.; Yang K.; Kumar A.; Wang P.C.; Zhang J.; Hu Z.; Liang X.J.; Ultrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entry. ACS Nano 2014,8(6),5852-5862","journal-title":"ACS Nano"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"86675","DOI":"10.18632\/oncotarget.13431","volume":"7","author":"Xue H.Y.","year":"2016","unstructured":"Xue H.Y.; Liu Y.; Liao J.Z.; Lin J.S.; Li B.; Yuan W.G.; Lee R.J.; Li L.; Xu C.R.; He X.X.; Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma. Oncotarget 2016,7(52),86675-86686","journal-title":"Oncotarget"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.burns.2006.06.010","volume":"33","author":"Atiyeh B.S.","year":"2007","unstructured":"Atiyeh B.S.; Costagliola M.; Hayek S.N.; Dibo S.A.; Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007,33(2),139-148","journal-title":"Burns"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1021\/nn304868y","volume":"7","author":"Brown P.K.","year":"2013","unstructured":"Brown P.K.; Qureshi A.T.; Moll A.N.; Hayes D.J.; Monroe W.T.; Silver nanoscale antisense drug delivery system for photoactivated gene silencing. ACS Nano 2013,7(4),2948-2959","journal-title":"ACS Nano"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/nnm.10.114","volume":"5","author":"Frimpong R.A.","year":"2010","unstructured":"Frimpong R.A.; Hilt J.Z.; Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications. Nanomedicine (Lond) 2010,5(9),1401-1414","journal-title":"Nanomedicine (Lond)"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0921-5093(00)00628-6","volume":"286","author":"Sun X.C.","year":"2000","unstructured":"Sun X.C.; Gutierrez A.; Yacaman M.J.; Dong X.L.; Jin S.; Investigations on magnetic properties and structure for carbon encapsulated nanoparticles of Fe, Co, Ni. Mater. Sci. Eng. A-Struct. Mater Prop Microstruct Process 2000,286(1),157-160","journal-title":"Mater Prop Microstruct Process"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jmmm.2007.08.010","volume":"320","author":"Giri J.","year":"2008","unstructured":"Giri J.; Pradhan P.; Somani V.; Chelawat H.; Chhatre S.; Banerjee R.; Bahadur D.; Synthesis and characterizations of water-based ferrofluids of substituted ferrites Fe1-xBxFeO, B=Mn, Co (x=0-1) for biomedical applications. J Magn Magn Mater 2008,320(5),724-730","journal-title":"J Magn Magn Mater"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/tx800064j","volume":"21","author":"Karlsson H.L.","year":"2008","unstructured":"Karlsson H.L.; Cronholm P.; Gustafsson J.; M\u00f6ller L.; Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008,21(9),1726-1732","journal-title":"Chem Res Toxicol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/cnma.201600021","volume":"2","author":"Meka A.K.","year":"2016","unstructured":"Meka A.K.; Niu Y.; Karmakar S.; Hartono S.B.; Zhang J.; Lin C.X.C.; Zhang H.; Whittaker A.; Jack K.; Yu M.; Facile synthesis of large-pore bicontinuous cubic mesoporous silica nanoparticles for intracellular gene delivery. ChemNanoMat 2016,2(3),220-225","journal-title":"ChemNanoMat"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"12492","DOI":"10.1021\/ja053962k","volume":"127","author":"Kam N.W.","year":"2005","unstructured":"Kam N.W.; Liu Z.; Dai H.; Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005,127(36),12492-12493","journal-title":"J Am Chem Soc"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","volume":"15","author":"Gon\u00e7alves G.A.R.","year":"2017","unstructured":"Gon\u00e7alves G.A.R.; Paiva R.M.A.; Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo) 2017,15(3),369-375","journal-title":"Einstein (Sao Paulo)"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0168-3659(02)00129-3","volume":"82","author":"Bieber T.","year":"2002","unstructured":"Bieber T.; Meissner W.; Kostin S.; Niemann A.; Elsasser H.P.; Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J Control Release 2002,82(2-3),441-454","journal-title":"J Control Release"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.gt.3301666","volume":"9","author":"Orson F.M.","year":"2002","unstructured":"Orson F.M.; Song L.; Gautam A.; Densmore C.L.; Bhogal B.S.; Kinsey B.M.; Gene delivery to the lung using protein\/polyethylenimine\/plasmid complexes. Gene Ther 2002,9(7),463-471","journal-title":"Gene Ther"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.cgt.7700432","volume":"9","author":"Jia S.F.","year":"2002","unstructured":"Jia S.F.; Worth L.L.; Densmore C.L.; Xu B.; Zhou Z.; Kleinerman E.S.; Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther 2002,9(3),260-266","journal-title":"Cancer Gene Ther"},{"key":"ref=110","first-page":"e1800068","volume":"40","author":"Zhang Z","year":"2018","unstructured":"Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping, Y Cationic polymer-mediated\n\tCRISPR\/Cas9 plasmid delivery for genome editing.  2018,40(5),e1800068"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0378-5173(98)00378-0","volume":"178","author":"Richardson S.C.","year":"1999","unstructured":"Richardson S.C.; Kolbe H.V.; Duncan R.; Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 1999,178(2),231-243","journal-title":"Int J Pharm"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1021\/cr030441b","volume":"104","author":"Kumar M.N.","year":"2004","unstructured":"Kumar M.N.; Muzzarelli R.A.; Muzzarelli C.; Sashiwa H.; Domb A.J.; Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004,104(12),6017-6084","journal-title":"Chem Rev"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10731199009117286","volume":"18","author":"Chandy T.","year":"1990","unstructured":"Chandy T.; Sharma C.P.; Chitosan--as a biomaterial. Biomater Artif Cells Artif Organs 1990,18(1),1-24","journal-title":"Biomater Artif Cells Artif Organs"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/jbm.a.31479","volume":"84","author":"Xu X.","year":"2008","unstructured":"Xu X.; Capito R.M.; Spector M.; Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes. J Biomed Mater Res A 2008,84(4),1038-1048","journal-title":"J Biomed Mater Res A"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","volume":"13","author":"Kulkarni J.A.","year":"2017","unstructured":"Kulkarni J.A.; Myhre J.L.; Chen S.; Tam Y.Y.C.; Danescu A.; Richman J.M.; Cullis P.R.; Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine (Lond) 2017,13(4),1377-1387","journal-title":"Nanomedicine (Lond)"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature08956","volume":"464","author":"Davis M.E.","year":"2010","unstructured":"Davis M.E.; Zuckerman J.E.; Choi C.H.; Seligson D.; Tolcher A.; Alabi C.A.; Yen Y.; Heidel J.D.; Ribas A.; Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010,464(7291),1067-1070","journal-title":"Nature"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.ymthe.2018.04.023","volume":"26","author":"Pursell N.","year":"2018","unstructured":"Pursell N.; Gierut J.; Zhou W.; Dills M.; Diwanji R.; Gjorgjieva M.; Saxena U.; Yang J.S.; Shah A.; Venkat N.; Inhibition of glycogen synthase II with RNAi prevents liver injury in mouse models of glycogen storage diseases. Mol Ther 2018,26(7),1771-1728","journal-title":"Mol Ther"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/ph6030287","volume":"6","author":"Pauley K.M.","year":"2013","unstructured":"Pauley K.M.; Cha S.; RNAi Therapeutics in autoimmune disease. Pharmaceuticals (Basel) 2013,6(3),287-294","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","volume":"127","author":"Majmudar M.D.","year":"2013","unstructured":"Majmudar M.D.; Keliher E.J.; Heidt T.; Leuschner F.; Truelove J.; Sena B.F.; Gorbatov R.; Iwamoto Y.; Dutta P.; Wojtkiewicz G.; Courties G.; Sebas M.; Borodovsky A.; Fitzgerald K.; Nolte M.W.; Dickneite G.; Chen J.W.; Anderson D.G.; Swirski F.K.; Weissleder R.; Nahrendorf M.; Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 2013,127(20),2038-2046","journal-title":"Circulation"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1021\/bc100199c","volume":"21","author":"Musacchio T.","year":"2010","unstructured":"Musacchio T.; Vaze O.; D\u2019Souza G.; Torchilin V.P.; Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjug Chem 2010,21(8),1530-1536","journal-title":"Bioconjug Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1073\/pnas.0701458104","volume":"104","author":"Heidel J.D.","year":"2007","unstructured":"Heidel J.D.; Yu Z.; Liu J.Y.; Rele S.M.; Liang Y.; Zeidan R.K.; Kornbrust D.J.; Davis M.E.; Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA 2007,104(14),5715-5721","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"Morrissey D.V.","year":"2005","unstructured":"Morrissey D.V.; Lockridge J.A.; Shaw L.; Blanchard K.; Jensen K.; Breen W.; Hartsough K.; Machemer L.; Radka S.; Jadhav V.; Vaish N.; Zinnen S.; Vargeese C.; Bowman K.; Shaffer C.S.; Jeffs L.B.; Judge A.; MacLachlan I.; Polisky B.; Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005,23(8),1002-1007","journal-title":"Nat Biotechnol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","volume":"145","author":"Sahay G.","year":"2010","unstructured":"Sahay G.; Alakhova D.Y.; Kabanov A.V.; Endocytosis of nanomedicines. J Control Release 2010,145(3),182-195","journal-title":"J Control Release"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Sato Y.","year":"2008","unstructured":"Sato Y.; Murase K.; Kato J.; Kobune M.; Sato T.; Kawano Y.; Takimoto R.; Takada K.; Miyanishi K.; Matsunaga T.; Takayama T.; Niitsu Y.; Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008,26(4),431-442","journal-title":"Nat Biotechnol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1166\/jnn.2015.11233","volume":"15","author":"Che H.L.","year":"2015","unstructured":"Che H.L.; Lee H.J.; Uto K.; Ebara M.; Kim W.J.; Aoyagi T.; Park I.K.; Simultaneous drug and gene delivery from the biodegradable Poly(\u03b5-caprolactone) nanofibers for the treatment of liver cancer. J Nanosci Nanotechnol 2015,15(10),7971-7975","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1021\/mp300081s","volume":"9","author":"Cheng C.J.","year":"2012","unstructured":"Cheng C.J.; Saltzman W.M.; Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing. Mol Pharm 2012,9(5),1481-1488","journal-title":"Mol Pharm"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.biomaterials.2014.02.006","volume":"35","author":"Deng X.","year":"2014","unstructured":"Deng X.; Cao M.; Zhang J.; Hu K.; Yin Z.; Zhou Z.; Xiao X.; Yang Y.; Sheng W.; Wu Y.; Zeng Y.; Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials 2014,35(14),4333-4344","journal-title":"Biomaterials"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"13567","DOI":"10.1038\/srep13567","volume":"5","author":"Santos-Carballal B.","year":"2015","unstructured":"Santos-Carballal B.; Aaldering L.J.; Ritzefeld M.; Pereira S.; Sewald N.; Moerschbacher B.M.; G\u00f6tte M.; Goycoolea F.M.; Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells. Sci Rep 2015,5,13567","journal-title":"Sci Rep"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/adhm.201400222","volume":"4","author":"Wang S.","year":"2015","unstructured":"Wang S.; Cao M.; Deng X.; Xiao X.; Yin Z.; Hu Q.; Zhou Z.; Zhang F.; Zhang R.; Wu Y.; Sheng W.; Zeng Y.; Degradable hyaluronic acid\/protamine sulfate interpolyelectrolyte complexes as miRNA-delivery nanocapsules for triple-negative breast cancer therapy. Adv Healthc Mater 2015,4(2),281-290","journal-title":"Adv Healthc Mater"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jconrel.2013.09.027","volume":"172","author":"Wang X.","year":"2013","unstructured":"Wang X.; Yu B.; Ren W.; Mo X.; Zhou C.; He H.; Jia H.; Wang L.; Jacob S.T.; Lee, RJ Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release 2013,172(3),690-698","journal-title":"J Control Release"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1039\/c2nr31853a","volume":"4","author":"Xiao Y.","year":"2012","unstructured":"Xiao Y.; Jaskula-Sztul R.; Javadi A.; Xu W.; Eide J.; Dammalapati A.; Kunnimalaiyaan M.; Chen H.; Gong S.; Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. Nanoscale 2012,4(22),7185-7193","journal-title":"Nanoscale"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"8316","DOI":"10.1021\/nn3030223","volume":"6","author":"Conde J.","year":"2012","unstructured":"Conde J.; Ambrosone A.; Sanz V.; Hernandez Y.; Marchesano V.; Tian F.; Child H.; Berry C.C.; Ibarra M.R.; Baptista P.V.; Tortiglione C.; de la Fuente J.M.; Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 2012,6(9),8316-8324","journal-title":"ACS Nano"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1002\/smll.201400963","volume":"10","author":"Yin P.T.","year":"2014","unstructured":"Yin P.T.; Shah B.P.; Lee K.B.; Combined magnetic nanoparticle-based microRNA and hyperthermia therapy to enhance apoptosis in brain cancer cells. Small 2014,10(20),4106-4112","journal-title":"Small"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1002\/smll.201500540","volume":"11","author":"Bertucci A.","year":"2015","unstructured":"Bertucci A.; Prasetyanto E.A.; Septiadi D.; Manicardi A.; Brognara E.; Gambari R.; Corradini R.; De Cola L.; Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells. Small 2015,11(42),5687-5695","journal-title":"Small"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"15593","DOI":"10.1002\/chem.201302736","volume":"19","author":"Ma X.","year":"2013","unstructured":"Ma X.; Zhao Y.; Ng K.W.; Zhao Y.; Integrated hollow mesoporous silica nanoparticles for target drug\/siRNA co-delivery. Chemistry 2013,19(46),15593-15603","journal-title":"Chemistry"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/10937404.2011.615113","volume":"14","author":"Zhao J.","year":"2011","unstructured":"Zhao J.; Castranova V.; Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev 2011,14(8),593-632","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1091581816631729","volume":"35","author":"Hobson D.W.","year":"2016","unstructured":"Hobson D.W.; Nanotoxicology: The toxicology of nanomaterials and nanostructures. Int J Toxicol 2016,35(1),3-4","journal-title":"Int J Toxicol"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/mt.2013.32","volume":"21","author":"Senzer N.","year":"2013","unstructured":"Senzer N.; Nemunaitis J.; Nemunaitis D.; Bedell C.; Edelman G.; Barve M.; Nunan R.; Pirollo K.F.; Rait A.; Chang E.H.; Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. Mol Ther 2013,21(5),1096-1103","journal-title":"Mol Ther"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/mt.2016.135","volume":"24","author":"Pirollo K.F.","year":"2016","unstructured":"Pirollo K.F.; Nemunaitis J.; Leung P.K.; Nunan R.; Adams J.; Chang E.H.; Safety and efficacy in advanced solid tumors of a targeted nanocomplex carrying the p53 gene used in combination with docetaxel: A phase 1b study. Mol Ther 2016,24(9),1697-1706","journal-title":"Mol Ther"},{"key":"ref=140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034833","volume":"7","author":"Lu C.","year":"2012","unstructured":"Lu C.; Stewart D.J.; Lee J.J.; Ji L.; Ramesh R.; Jayachandran G.; Nunez M.I.; Wistuba I.I.; Erasmus J.J.; Hicks M.E.; Grimm E.A.; Reuben J.M.; Baladandayuthapani V.; Templeton N.S.; McMannis J.D.; Roth J.A.; Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 2012,7(4)","journal-title":"PLoS One"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"Beg M.S.","year":"2017","unstructured":"Beg M.S.; Brenner A.J.; Sachdev J.; Borad M.; Kang Y.K.; Stoudemire J.; Smith S.; Bader A.G.; Kim S.; Hong D.S.; Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs 2017,35(2),180-188","journal-title":"Invest New Drugs"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/1078-0432.CCR-10-0978","volume":"16","author":"Libutti S.K.","year":"2010","unstructured":"Libutti S.K.; Paciotti G.F.; Byrnes A.A.; Alexander H.R.; Gannon W.E.; Walker M.; Seidel G.D.; Yuldasheva N.; Tamarkin L.; Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 2010,16(24),6139-6149","journal-title":"Clin Cancer Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.nano.2015.02.021","volume":"11","author":"van der Valk F.M.","year":"2015","unstructured":"van der Valk F.M.; van Wijk D.F.; Lobatto M.E.; Verberne H.J.; Storm G.; Willems M.C.; Legemate D.A.; Nederveen A.J.; Calcagno C.; Mani V.; Ramachandran S.; Paridaans M.P.; Otten M.J.; Dallinga-Thie G.M.; Fayad Z.A.; Nieuwdorp M.; Schulte D.M.; Metselaar J.M.; Mulder W.J.; Stroes E.S.; Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine (Lond) 2015,11(5),1039-1046","journal-title":"Nanomedicine (Lond)"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1158\/1078-0432.CCR-15-2548","volume":"22","author":"Von Hoff D.D.","year":"2016","unstructured":"Von Hoff D.D.; Mita M.M.; Ramanathan R.K.; Weiss G.J.; Mita A.C.; LoRusso P.M.; Burris H.A.; Hart L.L.; Low S.C.; Parsons, DM phase I study of PSMA-targeted docetaxel-containing nanoparticle bind-014 in patients with advanced solid tumors. Clin Cancer Res 2016,22(13),3157-3163","journal-title":"Clin Cancer Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/eurheartj\/ehs366","volume":"34","author":"Yilmaz A.","year":"2013","unstructured":"Yilmaz A.; Dengler M.A.; van der Kuip H.; Yildiz H.; R\u00f6sch S.; Klumpp S.; Klingel K.; Kandolf R.; Helluy X.; Hiller K.H.; Jakob P.M.; Sechtem U.; Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J 2013,34(6),462-475","journal-title":"Eur Heart J"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.nano.2015.02.001","volume":"11","author":"Cortial A.","year":"2015","unstructured":"Cortial A.; Nosbaum A.; Rozi\u00e8res A.; Baeck M.; de Montjoye L.; Grande S.; Brian\u00e7on S.; Nicolas J.F.; Vocanson M.; Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis. Nanomedicine (Lond) 2015,11(4),1029-1033","journal-title":"Nanomedicine (Lond)"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ahj.2009.06.011","volume":"158","author":"Wilson S.R.","year":"2009","unstructured":"Wilson S.R.; Sabatine M.S.; Braunwald E.; Sloan S.; Murphy S.A.; Morrow D.A.; Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Am Heart J 2009,158(3),386-391","journal-title":"Am Heart J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1208760","volume":"369","author":"Coelho T.","year":"2013","unstructured":"Coelho T.; Adams D.; Silva A.; Lozeron P.; Hawkins P.N.; Mant T.; Perez J.; Chiesa J.; Warrington S.; Tranter E.; Munisamy M.; Falzone R.; Harrop J.; Cehelsky J.; Bettencourt B.R.; Geissler M.; Butler J.S.; Sehgal A.; Meyers R.E.; Chen Q.; Borland T.; Hutabarat R.M.; Clausen V.A.; Alvarez R.; Fitzgerald K.; Gamba-Vitalo C.; Nochur S.V.; Vaishnaw A.K.; Sah D.W.; Gollob J.A.; Suhr O.B.; Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 2013,369(9),819-829","journal-title":"N Engl J Med"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41467-017-00220-4","volume":"8","author":"Huang L.","year":"2017","unstructured":"Huang L.; Wan J.; Wei X.; Liu Y.; Huang J.; Sun X.; Zhang R.; Gurav D.D.; Vedarethinam V.; Li Y.; Chen R.; Qian K.; Plasmonic silver nanoshells for drug and metabolite detection. Nat Commun 2017,8(1),220","journal-title":"Nat Commun"},{"key":"ref=150","author":"Reynolds JL","unstructured":"Reynolds JL; Law WC; Mahajan SD; Aalinkeel R; Nair B;"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/anie.200604295","volume":"46","author":"Liu Z.","year":"2007","unstructured":"Liu Z.; Winters M.; Holodniy M.; Dai H.; siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl 2007,46(12),2023-2027","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.nano.2015.06.008","volume":"11","author":"Gaspar M.M.","year":"2015","unstructured":"Gaspar M.M.; Calado S.; Pereira J.; Ferronha H.; Correia I.; Castro H.; Tom\u00e1s A.M.; Cruz M.E.; Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems. Nanomedicine (Lond) 2015,11(7),1851-1860","journal-title":"Nanomedicine (Lond)"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.nano.2019.02.014","volume":"18","author":"Pastor M.","year":"2019","unstructured":"Pastor M.; Basas J.; Vairo C.; Gainza G.; Moreno-Sastre M.; Gomis X.; Fleischer A.; Palomino E.; Bachiller D.; Guti\u00e9rrez F.B.; Aguirre J.J.; Esquisabel A.; Igartua M.; Gainza E.; Hernandez R.M.; Gavald\u00e0 J.; Pedraz J.L.; Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. Aeruginosa: In vitro and in vivo studies following pulmonary and intramuscular administration. Nanomedicine (Lond) 2019,18,101-111","journal-title":"Nanomedicine (Lond)"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/mp800157x","volume":"6","author":"Carmona S.","year":"2009","unstructured":"Carmona S.; Jorgensen M.R.; Kolli S.; Crowther C.; Salazar F.H.; Marion P.L.; Fujino M.; Natori Y.; Thanou M.; Arbuthnot P.; Miller A.D.; Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. Mol Pharm 2009,6(3),706-717","journal-title":"Mol Pharm"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","volume":"375","author":"Geisbert T.W.","year":"2010","unstructured":"Geisbert T.W.; Lee A.C.; Robbins M.; Geisbert J.B.; Honko A.N.; Sood V.; Johnson J.C.; de Jong S.; Tavakoli I.; Judge A.; Hensley L.E.; Maclachlan I.; Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010,375(9729),1896-1905","journal-title":"Lancet"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/infdis\/jit465","volume":"209","author":"Ursic-Bedoya R.","year":"2014","unstructured":"Ursic-Bedoya R.; Mire C.E.; Robbins M.; Geisbert J.B.; Judge A.; MacLachlan I.; Geisbert T.W.; Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA. J Infect Dis 2014,209(4),562-570","journal-title":"J Infect Dis"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T14:07:21Z","timestamp":1578492441000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176141\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,17]]},"references-count":156,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2019,12,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666191024170212","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}